L603-0191 Screening compound: N-(3-{5-[(2H-1,3-benzodioxol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}phenyl)-4-fluorobenzene-1-sulfonamide

L603-0191 Screening compound: N-(3-{5-[(2H-1,3-benzodioxol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}phenyl)-4-fluorobenzene-1-sulfonamide
L603-0191 Screening compound: N-(3-{5-[(2H-1,3-benzodioxol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}phenyl)-4-fluorobenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L603-0191
N-(3-{5-[(2H-1,3-benzodioxol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}phenyl)-4-fluorobenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L603-0191

Molecular Formula

C22H16FN3O5S (C22 H16 FN3 O5 S)

Compound Name

N-(3-{5-[(2H-1,3-benzodioxol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}phenyl)-4-fluorobenzene-1-sulfonamide

IUPAC name

N-(3-{5-[(2H-13-benzodioxol-5-yl)methyl]-134-oxadiazol-2-yl}phenyl)-4-fluorobenzene-1-sulfonamide

SMILES

O=S(c(cc1)ccc1F)(Nc1cc(-c2nnc(Cc(cc3)cc4c3OCO4)o2)ccc1)=O

InChI

InChI=1S/C22H16FN3O5S/c23-16-5-7-18(8-6-16)32(27,28)26-17-3-1-2-15(12-17)22-25-24-21(31-22)11-14-4-9-19-20(10-14)30-13-29-19/h1-10,12,26H,11,13H2

InChI Key

XJIUZJSNGZRSTJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27464741

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

453.45

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.290

Distribution Coefficient, logD

4.279

Water Solubility, LogSw

-4.50

Polar Surface Area

87.913

Acid Dissociation Constant (pKa)

8.96

Base Dissociation Constant (pKb)

-2.94

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.10

L603-0191 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Integrin Receptors Targeted library (1715 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Others
  • Kinases

References: we are preparing a list of scientific research reports with L603-0191 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L603-0191?
Check Price and Availability of L603-0191, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L603-0191 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L603-0191
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L603-0191
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L603-0191 available by request